FindTrial
Sign In

Intra-substance Steroid Injection for Full-thickness Supraspinatus Tendon Rupture

Intra-substance Steroid Injection for Full-thickness Supraspinatus Tendon Rupture

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026376
Enrollment
Unknown
Registered
2019-10-05
Start date
2017-01-01
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

??????????

Interventions

1:steroid intrasubstance injection for supraspinatus tendon
2:local anesthesia intrasubstance injection for supraspinatus tendon

Sponsors

Chung-Ting Liu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: patients with supraspinatus tendon full thickness rupture size between 1cm to 3cm

Exclusion criteria

Exclusion criteria: patients has willing to receieve surgery

Design outcomes

Primary

MeasureTime frame
sonography;Shoulder Pain and Disability Index (SPADI) score;Pain Visual Analogue Scale (VAS) score;—

Countries

China

Contacts

Public ContactChung-Ting Liu

Mackay Memorial Hospital, Taipei

timo9001099@gmail.com+886-935137476

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026